Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27773806.
- Also identified by DOI 10.1053/j.gastro.2016.09.065 and PMC identifier 5193106.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Technologies such as genome sequencing, gene expression profiling, proteomic and metabolomic analyses, electronic medical records, and patient-reported health information have produced large amounts of data from various populations, cell types, and disorders (big data). However, these data must be integrated and analyzed if they are to produce models or concepts about physiological function or mechanisms of pathogenesis. Many of these data are available to the public, allowing researchers anywhere to search for markers of specific biological processes or therapeutic targets for specific diseases or patient types. We review recent advances in the fields of computational and systems biology and highlight opportunities for researchers to use big data sets in the fields of gastroenterology and hepatology to complement traditional means of diagnostic and therapeutic discovery.
Medical subject headings
- Computational Biology
- Drug Discovery
- Gastrointestinal Diseases
- Liver Diseases